 TORONTO, May 25, 2021 GLOBE NEWSWIRE -- Profound Medical Corp. TSX: PRN; NASDAQ: PROF Profound or the Company, a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, announced today that management will participate in two investor conferences in June. 